ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Fragmin Cuts Risk Of VE By 50 Percent In Study

January 31, 2003

Childhood cancer Death Rates Decline, Incidence Stable, NCI Says In Report

July 30, 1999

SSO Workshop Calls For Certification of Surgical Oncologists, Increased Commitments By NCI, ACS

November 18, 1983

NCI Considering Combining Support, Control Core Grants; Directors Reject Two Grants, One Review

June 2, 1978

NCI Plans $175 Million In Program Cuts To Cover Deficit, Fund New Initiatives

November 17, 2006

Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices

June 26, 1992